It can be seen in Fig. 3 that MLH1-hypermethylated tumors among MMR-D tumors were common in GC (94.8%, 55/58), CRC (82.0%, 50/61), and EC (75.0%,51/68). This evidence concerns the gene MLH1 and colorectal carcinoma.